HEMATOLOGY

>

Latest News

Updates on Recent Advances and Treatments for Hematologic Malignancies
Updates on Recent Advances and Treatments for Hematologic Malignancies

March 22nd 2023

In an interview with Targeted Oncology, Guenther Koehne, MD, PhD, provided an overview of The Summit of Americas on Immunotherapies for Hematologic Malignancies and some of the recent and exciting advances being seen in the hematology space.

Clinical Commentary: Addressing Treatment Tactics in Blastic Plasmacytoid Dendritic Cell Neoplasms
Clinical Commentary: Addressing Treatment Tactics in Blastic Plasmacytoid Dendritic Cell Neoplasms

March 20th 2023

Trial to Assess PRT2527 Plus Zanubrutinib for Hematologic Malignancies
Trial to Assess PRT2527 Plus Zanubrutinib for Hematologic Malignancies

March 18th 2023

Magrolimab Plus Azacitidine Achieves Complete Responses in Higher-Risk MDS
Magrolimab Plus Azacitidine Achieves Complete Responses in Higher-Risk MDS

March 15th 2023

Using NCCN Guidelines for Chronic GVHD Therapy in Clinical Practice
Using NCCN Guidelines for Chronic GVHD Therapy in Clinical Practice

March 9th 2023

More News